XML 93 R62.htm IDEA: XBRL DOCUMENT v3.25.1
SHAREHOLDERS' EQUITY - Summary Of Employee Options Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 29, 2022
Dec. 31, 2024
Dec. 31, 2023
Number of options      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 160,576    
Share-based Payment Arrangement, Option      
Number of options      
Outstanding, balance   3,956,056  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross   74,814  
Exercised   (828,721)  
Forfeited   (36,516)  
Outstanding, balance   3,165,633 3,956,056
Exercisable options at the end of the year   2,937,959  
Options vested and expected to vest at the end of the year   3,158,931  
Weighted average exercise price      
Outstanding, weighted average exercise price   $ 97.93  
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price   116.94  
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price   60.41  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price   127.07  
Outstanding, weighted average exercise price   107.86 $ 97.93
Exercisable, weighted average exercise price   105.47  
Options vested and expected to vest at the end of the year   $ 107.82  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term   4 years 4 months 17 days 4 years 11 months 4 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term   4 years 1 month 17 days  
Outstanding at the beginning of the year, aggregate intrinsic value   $ 167,822  
Outstanding at the ending of the year, aggregate intrinsic value   355,730 $ 167,822
Exercisable, aggregate intrinsic value   337,444  
Options vested and expected to vest at the end of the year, aggregate intrinsic value   $ 355,108